Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,122,364
-$1,410,570 QoQ
Shares Held
5,815
-25.3% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#137
of 411 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. MDGL ranks #55 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
|
275,209 | $14,974,121 |
All Filings in MDGL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,122,364 | 5,815 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $4,532,934 | 7,784 | Shares | Sole | 2026-02-17 | |
| 2023-06-30 | $1,492,260 | 6,460 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,322,739 | 5,460 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,247,897 | 11,190 | Shares | Sole | 2023-02-13 | |
| 2021-06-30 | $202,612 | 2,080 | Shares | Sole | 2021-08-12 | |
| 2020-09-30 | $291,125 | 2,452 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $490,485 | 4,331 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $336,003 | 5,033 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||